• Please log in or register to access this feature.

Research-Article

You have full text access to this OnlineOpen article

Clinical Risk Factors for Fractures in Multi-Ethnic Women: The Women's Health Initiative†

  1. Jane A Cauley1,*,
  2. LieLing Wu2,
  3. Nina S Wampler3,
  4. Janice M Barnhart4,
  5. Matthew Allison5,
  6. Zhao Chen6,
  7. Rebecca Jackson7,
  8. John Robbins8

Article first published online: 16 JUL 2007

DOI: 10.1359/jbmr.070713

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 22, Issue 11, pages 1816–1826, November 2007

Additional Information

How to Cite

Cauley, J. A., Wu, L., Wampler, N. S., Barnhart, J. M., Allison, M., Chen, Z., Jackson, R. and Robbins, J. (2007), Clinical Risk Factors for Fractures in Multi-Ethnic Women: The Women's Health Initiative. J Bone Miner Res, 22: 1816–1826. doi: 10.1359/jbmr.070713

Author Information

  1. 1

    Department of Epidemiology, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, Pennsylvania, USA

  2. 2

    Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

  3. 3

    Noqsi Research, Ltd., Pine, Colorado, USA

  4. 4

    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, New York, USA

  5. 5

    University of California, San Diego, La Jolla, California, USA

  6. 6

    Division of Epidemiology and Biostatistics, University of Arizona, Tucson, Arizona, USA

  7. 7

    Department of Internal Medicine and Physical Medicine, Ohio State University, Columbus, Ohio, USA

  8. 8

    Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, California, USA

*Address reprint requests to: Jane A Cauley, DrPH\ University of Pittsburgh, Department of Epidemiology, 130 DeSoto Street, Crabtree A524, Pittsburgh, PA 15261, USA

  1. †

    Dr Cauley has received research support from Merck & Company, Eli Lilly & Company, Pfizer Pharmaceuticals, and Novartis Pharmaceuticals. She has also received consulting fees from Eli Lilly & Company and Novartis Pharmaceuticals. She is on the speaker's bureau for Merck and Company. All other authors state they have no conflicts of interest.

Publication History

  1. Issue published online: 4 DEC 2009
  2. Article first published online: 16 JUL 2007
  3. Manuscript Accepted: 11 JUL 2007
  4. Manuscript Revised: 1 JUN 2007
  5. Manuscript Received: 5 MAR 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (1328K)

REFERENCES

  • 1
    Melton LJ III, Chrischilles EA, Cooper C, Lane AW, Riggs BL 1992 Perspective. How many women have osteoporosis? J Bone Miner Res 7: 1005–1010.
    Direct Link:
  • 2
    Farmer ME, White LR, Brody JA, Bailey KR 1984 Race and sex differences in hip fracture incidence. Am J Public Health 74: 1374–1380.
  • 3
    Baron JA, Karagas M, Barrett J, Kniffin W, Malenka D, Mayor M, Keller RB 1996 Basic epidemiology of fractures of the upper and lower limb among Americans over 65 years of age. Epidemiology 7: 612–618.
  • 4
    Baron JA, Barrett J, Malenka D, Fisher E, Kniffin W, Bubolz T, Tosteson T 1994 Racial differences in fracture risk. Epidemiology 5: 42–47.
  • 5
    Zingmond DS, Melton LJ III, Silverman SL 2004 Increasing hip fracture incidence in California Hispanics, 1983 to 2000. Osteoporos Int 15: 603–610.
  • 6
    Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA 1992 Race and sex differences in mortality following fracture of the hip. Am J Public Health 82: 1147–1150.
  • 7
    Furstenberg AL, Mezey MD 1987 Differences in outcome between black and white elderly hip fracture patients. J Chronic Dis 40: 931–938.
  • 8
    Ma J, Markides KS, Perkowski LP, Stroup-Benham CA, Lichtenstein M, Goodwin JS 1998 Impact of selected medical conditions on self-reported lower-extremity function in Mexican-American elderly. Ethn Dis 8: 52–59.
  • 9
    United States Public Health Service, Office of the Surgeon General 2004 Bone Health and Osteoporosis: A Report of the Surgeon General. U.S. Dept. of Health and Human Services Public Health Service Office of the Surgeon General, Rockville, MD, USA.
  • 10
    Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332: 767–773.
  • 11
    The Women's Health Initiative Study Group 1998 Design of the Women's Health Initiaitve Clinical Trial and Observational Study. Control Clin Trials 19: 61–109.
  • 12
    Andresen EM, Malmgren JA, Carter WB, Patrick DL 1994 Screening for depression in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 10: 77–84.
  • 13
    Chen Z, Kooperberg C, Pettinger MB, Bassford T, Cauley JA, LaCroix AZ, Lewis CE, Kipersztok S, Borne C, Jackson RD 2004 Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: Results from the Women's Health Initiative observational study and clinical trials. Menopause 11: 264–274.
  • 14
    Cummings SR, Melton LJ 2002 Epidemiology and outcomes of osteoporotic fractures. Lancet 359: 1761–1767.
  • 15
    Barrett-Connor E, Siris ES, Wehren LE, Miller PD, Abbott TA, Berger ML, Santora AC, Sherwood LM 2005 Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 20: 185–194.
    Direct Link:
  • 16
    Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB 2003 Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initiative randomized trial. JAMA 290: 1729–1738.
  • 17
    Jackson RD, Wactawski-Wende J, LaCroix AZ, Pettinger M, Yood RA, Watts NB, Robbins JA, Lewis CE, Beresford SA, Ko MG, Naughton MJ, Satterfield S, Bassford T 2006 Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: Results from the women's health initiative randomized trial. J Bone Miner Res 21: 817–828.
    Direct Link:
  • 18
    Grisso JA, Kelsey JL, Strom BL, O'Brien LA, Maislin G, LaPann K, Samelson L, Hoffman S 1994 Risk factors for hip fracture in black women. The Northeast Hip Fracture Study Group. N Engl J Med 330: 1555–1559.
  • 19
    Fujiwara S, Kasagi F, Yamada M, Kodama K 1997 Risk factors for hip fracture in a Japanese cohort. J Bone Miner Res 12: 998–1004.
    Direct Link:
  • 20
    Grisso JA, Kelsey JL, O'Brien LA, Miles CG, Sidney S, Maislin G, LaPann K, Moritz D, Peters B 1997 Risk factors for hip fracture in men. Hip Fracture Study Group. Am J Epidemiol 145: 786–793.
  • 21
    Pruzansky ME, Turano M, Luckey M, Seinie R 1989 Low body weight as a risk factor for hip fracture in both black and white women. J Orthop Res 7: 192–197.
    Direct Link:
  • 22
    Margolis KL, Ensrud KE, Schreiner PJ, Tabor HK 2000 Body size and risk for clinical fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 133: 123–127.
  • 23
    Espino DV, Palmer RF, Miles TP, Mouton CP, Wood RC, Bayne NS, Markides KP 2000 Prevalence, incidence, and risk factors associated with hip fractures in community-dwelling older Mexican Americans: Results of the Hispanic EPESE study. Establish Population for the Epidemiologic Study for the Elderly. J Am Geriatr Soc 48: 1252–1260.
  • 24
    Xu L, Lu A, Zhao X, Chen X, Cummings SR 1996 Very low rates of hip fracture in Beijing, People's Republic of China the Beijing Osteoporosis Project. Am J Epidemiol 144: 901–907.
  • 25
    Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC, Tylavsky FA, de Rekeneire N, Harris TB, Newman AB 2005 Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: The health, aging, and body composition study. Arch Intern Med 165: 1612–1617.
  • 26
    Ottenbacher KJ, Ostir GV, Peek MK, Goodwin JS, Markides KS 2002 Diabetes mellitus as a risk factor for hip fracture in mexican american older adults. J Gerontol A Biol Sci Med Sci 57: M648–M653.
  • 27
    Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS 1999 Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159: 484–490.
  • 28
    Hillier T, Rizzo JH, Pedula KL, Stone KL, Cauley JA, Bauer DC, Cummings SR 2003 Nulliparity and fracture risk in older women: The Study of Osteoporotic Fractures. J Bone Miner Res 18: 893–899.
    Direct Link:
  • 29
    Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D 2006 Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354: 669–683.
  • 30
    Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A, Hanlon JT, Nevitt MC, Whooley MA, Group So OFR 2003 Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163: 949–957.
  • 31
    Cauley JA, Cummings SR, Seeley DG, Black D, Browner W, Kuller LH, Nevitt MC 1993 Effects of thiazide diuretic therapy on bone mass, fractures, and falls. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 118: 666–673.
  • 32
    Bauer DC, Orwoll ES, Fox KM, Vogt TM, Lane NE, Hochberg MC, Stone K, Nevitt MC 1996 Aspirin and NSAID use in older women: Effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11: 29–35.
    Direct Link:
  • 33
    Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, Bauer DC 2005 beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res 20: 613–618.
    Direct Link:
  • 34
    Bauer DC 1996 Thyroid hormone use and fractures. Arch Intern Med 156: 341–342.
  • 35
    Barrett JA, Baron JA, Karagas MR, Beach ML 1999 Fracture risk in the U.S. Medicare population. J Clin Epidemiol 52: 243–249.
  • 36
    Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW, Bowman BA 2002 Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 76: 187–192.
  • 37
    Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE 2005 Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90: 3215–3224.
  • 38
    Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB 2004 Effect of vitamin D on falls: A meta-analysis. JAMA 291: 1999–2006.
  • 39
    Holick MF 2006 High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81: 353–373.
  • 40
    Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay RL 1995 Proximal femur bone mineral levels of US adults. Osteoporos Int 5: 389–409.
  • 41
    Mikuls TR, Saag KG, George V, Mudano AS, Banerjee S 2005 Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fracture. J Rheumatol 32: 870–875.
  • 42
    Alam NM, Archer JA, Lee E 2004 Osteoporotic fragility fractures in African Americans: Under-recognized and undertreated. J Natl Med Assoc 96: 1640–1645.
  • 43
    Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ III, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N 2007 The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18: 1033–1046.
  • 44
    Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, Nevitt MC, Cummings SR 2003 BMD at multiple sites and risk of fracture of multiple types: Long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 18: 1947–1954.
    Direct Link:
  • 45
    Cauley JA, Lui LY, Ensrud KE, Zmuda JM, Stone KL, Hochberg MC, Cummings SR 2005 Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA 293: 2102–2108.
  • 46
    Deng HW, Mahaney MC, Williams JT, Li J, Conway T, Davies KM, Li JL, Deng H, Recker RR 2002 Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Genet Epidemiol 22: 12–25.
    Direct Link:
  • 47
    Ray NF, Chan JK, Thamer M, Melton LJ III 1997 Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 12: 24–35.
    Direct Link:
View Full Article (HTML) Get PDF (1328K)